Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-2570 in Active Psoriatic Arthritis (Phase II, Randomized, Double-Blind, Placebo-Controlled)
CTR20254967Phase 2Active
- Sponsor
- InventisBio
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of D-2570 in psoriatic arthritis (PsA), sponsored by InventisBio. Started Jan 2026; status: active.
02
Drugs
D-2570
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on CTR20254967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254967.